In contrast, the NOS2−/CD8− phenotypes were observed in immune dessert regions, whereas the NOS2+ phenotypes in deceased patient tumors had stroma-restricted CD8+ T cells, and high tumor NOS2 expression was observed at the tumor margins. The gene discussed is NOS2; the disease is neoplasm.